In this study, we tried to use two-sample MR methods to unveil the causal effect of uromodulin on hypertension, systolic blood pressure (SBP), and diastolic blood pressure (DBP) using increasingly available public genome-wide association studies (GWAS) datasets. Here, UMOD is linked to Hypertension.